China Human Respiratory Syncytial Virus Drugs Industry 2017 Market Research Report

 Table of Contents

China Human Respiratory Syncytial Virus Drugs Market Research Report 2017
1 Human Respiratory Syncytial Virus Drugs Market Overview
    1.1 Product Overview and Scope of Human Respiratory Syncytial Virus Drugs
    1.2 Human Respiratory Syncytial Virus Drugs Segment by Type
        1.2.1 China Production Market Share of Human Respiratory Syncytial Virus Drugs Type in 2015
        1.2.2 Approved Drugs
        1.2.3 Off-Label Drugs
    1.3 Applications of Human Respiratory Syncytial Virus Drugs
        1.3.1 Human Respiratory Syncytial Virus Drugs Consumption Market Share by Application in 2015
        1.3.2 Hospitals
        1.3.3 Clinics
    1.4 China Market Size (Value) of Human Respiratory Syncytial Virus Drugs (2012-2022)
    1.5 China Human Respiratory Syncytial Virus Drugs Status and Outlook
    1.6 Government Policies

2 China Human Respiratory Syncytial Virus Drugs Market Competition by Manufacturers
    2.1 China Human Respiratory Syncytial Virus Drugs Capacity, Production and Share by Manufacturers (2015 and 2016)
    2.2 China Human Respiratory Syncytial Virus Drugs Revenue and Share by Manufacturers (2015 and 2016)
    2.3 China Human Respiratory Syncytial Virus Drugs Average Price by Manufacturers (2015 and 2016)
    2.4 Manufacturers Human Respiratory Syncytial Virus Drugs Manufacturing Base Distribution, Sales Area, Product Type
    2.5 Human Respiratory Syncytial Virus Drugs Market Competitive Situation and Trends
        2.5.1 Human Respiratory Syncytial Virus Drugs Market Concentration Rate
        2.5.2 Human Respiratory Syncytial Virus Drugs Market Share of Top 3 and Top 5 Manufacturers

3 China Human Respiratory Syncytial Virus Drugs Manufacturers Profiles/Analysis
    3.1 AstraZeneca
        3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        3.1.2 Human Respiratory Syncytial Virus Drugs Product Type, Application and Specification
            3.1.2.1 Product A
            3.1.2.2 Product B
        3.1.3 AstraZeneca Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        3.1.4 Main Business/Business Overview
    3.2 AbbVie
        3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        3.2.2 Human Respiratory Syncytial Virus Drugs Product Type, Application and Specification
            3.2.2.1 Product A
            3.2.2.2 Product B
        3.2.3 AbbVie Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        3.2.4 Main Business/Business Overview
    3.3 GSK
        3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        3.3.2 Human Respiratory Syncytial Virus Drugs Product Type, Application and Specification
            3.3.2.1 Product A
            3.3.2.2 Product B
        3.3.3 GSK Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        3.3.4 Main Business/Business Overview
    3.4 Teva Pharmaceutical
        3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        3.4.2 Human Respiratory Syncytial Virus Drugs Product Type, Application and Specification
            3.4.2.1 Product A
            3.4.2.2 Product B
        3.4.3 Teva Pharmaceutical Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        3.4.4 Main Business/Business Overview
    3.5 Ablynx
        3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        3.5.2 Human Respiratory Syncytial Virus Drugs Product Type, Application and Specification
            3.5.2.1 Product A
            3.5.2.2 Product B
        3.5.3 Ablynx Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        3.5.4 Main Business/Business Overview
    3.6 ADMA Biologics
        3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        3.6.2 Human Respiratory Syncytial Virus Drugs Product Type, Application and Specification
            3.6.2.1 Product A
            3.6.2.2 Product B
        3.6.3 ADMA Biologics Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        3.6.4 Main Business/Business Overview
    3.7 Alnylam Pharmaceuticals
        3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        3.7.2 Human Respiratory Syncytial Virus Drugs Product Type, Application and Specification
            3.7.2.1 Product A
            3.7.2.2 Product B
        3.7.3 Alnylam Pharmaceuticals Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        3.7.4 Main Business/Business Overview
    3.8 Ark Biosciences
        3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        3.8.2 Human Respiratory Syncytial Virus Drugs Product Type, Application and Specification
            3.8.2.1 Product A
            3.8.2.2 Product B
        3.8.3 Ark Biosciences Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        3.8.4 Main Business/Business Overview
    3.9 Aviragen Therapeutics
        3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        3.9.2 Human Respiratory Syncytial Virus Drugs Product Type, Application and Specification
            3.9.2.1 Product A
            3.9.2.2 Product B
        3.9.3 Aviragen Therapeutics Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        3.9.4 Main Business/Business Overview
    3.10 Bavarian Nordic
        3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        3.10.2 Human Respiratory Syncytial Virus Drugs Product Type, Application and Specification
            3.10.2.1 Product A
            3.10.2.2 Product B
        3.10.3 Bavarian Nordic Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        3.10.4 Main Business/Business Overview
    3.11 Boehringer Ingelheim
    3.12 Gilead Sciences
    3.13 ImmunoVaccine Technologies
    3.14 Johnson & Johnson
    3.15 Kyowa Hakko Kirin
    3.16 Medivir, Mucosis
    3.17 Mymetics
    3.18 Novavax
    3.19 Regeneron Pharmaceuticals
    3.20 ReViral
    3.21 Vaxart

4 China Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Consumption, Export and Import (2012-2017)
    4.1 China Human Respiratory Syncytial Virus Drugs Capacity, Production and Growth (2012-2017)
    4.2 China Human Respiratory Syncytial Virus Drugs Revenue and Growth (2012-2017)
    4.3 China Human Respiratory Syncytial Virus Drugs Production, Consumption, Export and Import (2012-2017)

5 China Human Respiratory Syncytial Virus Drugs Production, Revenue (Value), Price Trend by Type
    5.1 China Human Respiratory Syncytial Virus Drugs Production and Market Share by Type (2012-2017)
    5.2 China Human Respiratory Syncytial Virus Drugs Revenue and Market Share by Type (2012-2017)
    5.3 China Human Respiratory Syncytial Virus Drugs Price by Type (2012-2017)
    5.4 China Human Respiratory Syncytial Virus Drugs Production Growth by Type (2012-2017)

6 China Human Respiratory Syncytial Virus Drugs Market Analysis by Application
    6.1 China Human Respiratory Syncytial Virus Drugs Consumption and Market Share by Application (2012-2017)
    6.2 China Human Respiratory Syncytial Virus Drugs Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Application
        6.3.2 Emerging Markets/Countries

7 ChinaHuman Respiratory Syncytial Virus Drugs Market Analysis by Regions (Provinces)
    7.1 China Human Respiratory Syncytial Virus Drugs Production, Production Value and Price by Regions (Provinces)(2012-2017)
        7.1.1 China Human Respiratory Syncytial Virus Drugs Production and Market Share by Regions (Provinces)(2012-2017)
        7.1.2 China Human Respiratory Syncytial Virus Drugs Production Value and Market Share by Regions (Provinces)(2012-2017)
        7.1.3 China Human Respiratory Syncytial Virus Drugs Sales Price by Regions (Provinces)(2012-2017)
    7.2 China Human Respiratory Syncytial Virus Drugs Consumption by Regions (Provinces)(2012-2017)
    7.3 China Human Respiratory Syncytial Virus Drugs Production, Consumption, Export and Import (2012-2017)

8 Human Respiratory Syncytial Virus Drugs Manufacturing Cost Analysis
    8.1 Human Respiratory Syncytial Virus Drugs Key Raw Materials Analysis
        8.1.1 Key Raw Materials
        8.1.2 Price Trend of Key Raw Materials
        8.1.3 Key Suppliers of Raw Materials
        8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
        8.2.1 Raw Materials
        8.2.2 Labor Cost
        8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Human Respiratory Syncytial Virus Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Human Respiratory Syncytial Virus Drugs Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Human Respiratory Syncytial Virus Drugs Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 China Human Respiratory Syncytial Virus Drugs Market Forecast (2017-2022)
    12.1 China Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue Forecast (2017-2022)
    12.2 China Human Respiratory Syncytial Virus Drugs Production, Import, Export and Consumption Forecast (2017-2022)
    12.3 China Human Respiratory Syncytial Virus Drugs Production Forecast by Type (2017-2022)
    12.4 China Human Respiratory Syncytial Virus Drugs Consumption Forecast by Application (2017-2022)
    12.5 China Human Respiratory Syncytial Virus Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
        12.5.1 China Human Respiratory Syncytial Virus Drugs Production Forecast by Regions (Provinces)(2017-2022)
        12.5.2 China Human Respiratory Syncytial Virus Drugs Consumption Forecast by Regions (Provinces)(2017-2022)
        12.5.3 China Human Respiratory Syncytial Virus Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
    12.6 Human Respiratory Syncytial Virus Drugs Price Forecast (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    Methodology
    Analyst Introduction
    Data Source

List of Tables and Figures

    Figure Picture of Human Respiratory Syncytial Virus Drugs
    Figure China Production Market Share of Human Respiratory Syncytial Virus Drugs by Type in 2015
    Figure Product Picture of Approved Drugs
    Table Major Manufacturers of Approved Drugs
    Figure Product Picture of Off-Label Drugs
    Table Major Manufacturers of Off-Label Drugs
    Table Human Respiratory Syncytial Virus Drugs Consumption Market Share by Application in 2015
    Figure Hospitals Examples
    Figure Clinics Examples
    Figure China Human Respiratory Syncytial Virus Drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Table China Human Respiratory Syncytial Virus Drugs Capacity of Key Manufacturers (2015 and 2016)
    Table China Human Respiratory Syncytial Virus Drugs Capacity Market Share of Key Manufacturers (2015 and 2016)
    Figure China Human Respiratory Syncytial Virus Drugs Capacity of Key Manufacturers in 2015
    Figure China Human Respiratory Syncytial Virus Drugs Capacity of Key Manufacturers in 2016
    Table China Human Respiratory Syncytial Virus Drugs Production of Key Manufacturers (2015 and 2016)
    Table China Human Respiratory Syncytial Virus Drugs Production Share by Manufacturers (2015 and 2016)
    Figure 2015 Human Respiratory Syncytial Virus Drugs Production Share by Manufacturers
    Figure 2016 Human Respiratory Syncytial Virus Drugs Production Share by Manufacturers
    Table China Human Respiratory Syncytial Virus Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
    Table China Human Respiratory Syncytial Virus Drugs Revenue Share by Manufacturers (2015 and 2016)
    Table 2015 China Human Respiratory Syncytial Virus Drugs Revenue Share by Manufacturers
    Table 2016 China Human Respiratory Syncytial Virus Drugs Revenue Share by Manufacturers
    Table China Market Human Respiratory Syncytial Virus Drugs Average Price of Key Manufacturers (2015 and 2016)
    Figure China Market Human Respiratory Syncytial Virus Drugs Average Price of Key Manufacturers in 2015
    Table Manufacturers Human Respiratory Syncytial Virus Drugs Manufacturing Base Distribution and Sales Area
    Table Manufacturers Human Respiratory Syncytial Virus Drugs Product Type
    Figure Human Respiratory Syncytial Virus Drugs Market Share of Top 3 Manufacturers
    Figure Human Respiratory Syncytial Virus Drugs Market Share of Top 5 Manufacturers
    Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table AstraZeneca Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    Figure AstraZeneca Human Respiratory Syncytial Virus Drugs Market Share (2012-2017)
    Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table AbbVie Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    Figure AbbVie Human Respiratory Syncytial Virus Drugs Market Share (2012-2017)
    Table GSK Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table GSK Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    Figure GSK Human Respiratory Syncytial Virus Drugs Market Share (2012-2017)
    Table Teva Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Teva Pharmaceutical Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    Figure Teva Pharmaceutical Human Respiratory Syncytial Virus Drugs Market Share (2012-2017)
    Table Ablynx Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Ablynx Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    Figure Ablynx Human Respiratory Syncytial Virus Drugs Market Share (2012-2017)
    Table ADMA Biologics Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table ADMA Biologics Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    Figure ADMA Biologics Human Respiratory Syncytial Virus Drugs Market Share (2012-2017)
    Table Alnylam Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Alnylam Pharmaceuticals Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    Figure Alnylam Pharmaceuticals Human Respiratory Syncytial Virus Drugs Market Share (2012-2017)
    Table Ark Biosciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Ark Biosciences Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    Figure Ark Biosciences Human Respiratory Syncytial Virus Drugs Market Share (2012-2017)
    Table Aviragen Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Aviragen Therapeutics Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    Figure Aviragen Therapeutics Human Respiratory Syncytial Virus Drugs Market Share (2012-2017)
    Table Bavarian Nordic Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Bavarian Nordic Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    Figure Bavarian Nordic Human Respiratory Syncytial Virus Drugs Market Share (2012-2017)
    Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Gilead Sciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table ImmunoVaccine Technologies Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Kyowa Hakko Kirin Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Medivir, Mucosis Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Mymetics Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Novavax Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Regeneron Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table ReViral Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Vaxart Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Figure China Human Respiratory Syncytial Virus Drugs Capacity, Production and Growth (2012-2017)
    Figure China Human Respiratory Syncytial Virus Drugs Revenue (Million USD) and Growth (2012-2017)
    Table China Human Respiratory Syncytial Virus Drugs Production, Consumption, Export and Import (2012-2017)
    Table China Human Respiratory Syncytial Virus Drugs Production by Type (2012-2017)
    Table China Human Respiratory Syncytial Virus Drugs Production Share by Type (2012-2017)
    Figure Production Market Share of Human Respiratory Syncytial Virus Drugs by Type (2012-2017)
    Figure 2015 Production Market Share of Human Respiratory Syncytial Virus Drugs by Type
    Table China Human Respiratory Syncytial Virus Drugs Revenue by Type (2012-2017)
    Table China Human Respiratory Syncytial Virus Drugs Revenue Share by Type (2012-2017)
    Figure Production Revenue Share of Human Respiratory Syncytial Virus Drugs by Type (2012-2017)
    Figure 2015 Revenue Market Share of Human Respiratory Syncytial Virus Drugs by Type
    Table China Human Respiratory Syncytial Virus Drugs Price by Type (2012-2017)
    Figure China Human Respiratory Syncytial Virus Drugs Production Growth by Type (2012-2017)
    Table China Human Respiratory Syncytial Virus Drugs Consumption by Application (2012-2017)
    Table China Human Respiratory Syncytial Virus Drugs Consumption Market Share by Application (2012-2017)
    Figure China Human Respiratory Syncytial Virus Drugs Consumption Market Share by Application in 2015
    Table China Human Respiratory Syncytial Virus Drugs Consumption Growth Rate by Application (2012-2017)
    Figure China Human Respiratory Syncytial Virus Drugs Consumption Growth Rate by Application (2012-2017)
    Table China Human Respiratory Syncytial Virus Drugs Production by Regions (Provinces)(2012-2017)
    Table China Human Respiratory Syncytial Virus Drugs Production Market Share by Regions (Provinces)(2012-2017)
    Table China Human Respiratory Syncytial Virus Drugs Production Value by Regions (Provinces)(2012-2017)
    Table China Human Respiratory Syncytial Virus Drugs Production Value Market Share by Regions (Provinces)(2012-2017)
    Table China Human Respiratory Syncytial Virus Drugs Sales Price by Regions (Provinces)(2012-2017)
    Table China Human Respiratory Syncytial Virus Drugs Consumption by Regions (Provinces)(2012-2017)
    Table China Human Respiratory Syncytial Virus Drugs Consumption Market Share by Regions (Provinces)(2012-2017)
    Table China Human Respiratory Syncytial Virus Drugs Production, Consumption, Export and Import (2012-2017)
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Human Respiratory Syncytial Virus Drugs
    Figure Manufacturing Process Analysis of Human Respiratory Syncytial Virus Drugs
    Figure Human Respiratory Syncytial Virus Drugs Industrial Chain Analysis
    Table Raw Materials Sources of Human Respiratory Syncytial Virus Drugs Major Manufacturers in 2015
    Table Major Buyers of Human Respiratory Syncytial Virus Drugs
    Table Distributors/Traders List
    Figure China Human Respiratory Syncytial Virus Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
    Figure China Human Respiratory Syncytial Virus Drugs Revenue and Growth Rate Forecast (2017-2022)
    Table China Human Respiratory Syncytial Virus Drugs Production, Import, Export and Consumption Forecast (2017-2022)
    Table China Human Respiratory Syncytial Virus Drugs Production Forecast by Type (2017-2022)
    Table China Human Respiratory Syncytial Virus Drugs Consumption Forecast by Application (2017-2022)
    Table China Human Respiratory Syncytial Virus Drugs Production Forecast by Regions (Provinces)(2017-2022)
    Table China Human Respiratory Syncytial Virus Drugs Consumption Forecast by Regions (Provinces)(2017-2022)
    Table China Human Respiratory Syncytial Virus Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)

 

To request a free sample copy of this report, please complete the form below.

Enter captcha code*

We never share your personal data. Privacy policy